Your browser doesn't support javascript.
loading
Rituximab for second desensitization in patients with rebound of donor-specific anti-HLA antibodies before T-replete haplo-transplant using high-dose post-transplant cyclophosphamide.
Garnier, Alice; Delbos, Florent; Guillaume, Thierry; Peterlin, Pierre; Le Bourgeois, Amandine; Béné, Marie C; Le Bris, Yannick; Malard, Stéphanie; Duquesne, Alix; Gauvrit, Isabelle; Moreau, Philippe; Cesbron, Anne; Chevallier, Patrice.
Afiliação
  • Garnier A; Hematology Department, Nantes University Hospital, Nantes, France.
  • Delbos F; HLA Laboratory, EFS Pays de la Loire, Nantes, France.
  • Guillaume T; Hematology Department, Nantes University Hospital, Nantes, France.
  • Peterlin P; Hematology Department, Nantes University Hospital, Nantes, France.
  • Le Bourgeois A; Hematology Department, Nantes University Hospital, Nantes, France.
  • Béné MC; Hematology/Biology Department, Nantes University Hospital, Nantes, France.
  • Le Bris Y; Hematology/Biology Department, Nantes University Hospital, Nantes, France.
  • Malard S; HLA Laboratory, EFS Pays de la Loire, Nantes, France.
  • Duquesne A; Cellular Engineering Unit, EFS Pays de la Loire, Nantes, France.
  • Gauvrit I; HLA Laboratory, EFS Pays de la Loire, Nantes, France.
  • Moreau P; Hematology Department, Nantes University Hospital, Nantes, France.
  • Cesbron A; HLA Laboratory, EFS Pays de la Loire, Nantes, France.
  • Chevallier P; Hematology Department, Nantes University Hospital, Nantes, France. patrice.chevallier@chu-nantes.fr.
Bone Marrow Transplant ; 53(8): 1044-1047, 2018 08.
Article em En | MEDLINE | ID: mdl-29391525

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ciclofosfamida / Rituximab / Antineoplásicos Imunológicos / Antígenos HLA / Imunossupressores Limite: Adult / Female / Humans / Middle aged Idioma: En Revista: Bone Marrow Transplant Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ciclofosfamida / Rituximab / Antineoplásicos Imunológicos / Antígenos HLA / Imunossupressores Limite: Adult / Female / Humans / Middle aged Idioma: En Revista: Bone Marrow Transplant Ano de publicação: 2018 Tipo de documento: Article